Zentralblatt für Gynäkologie
References
Aapro MS, van Wijk FH, Bolis G, Chevallier B, van der Burg MEL, Poveda A, de Oliveira CF, Tumolo S, Scotto di Palumbo V, Piccart M, Franchi M, Zanaboni F, Lacave AJ, Fontanelli R, Favalli G, Zola P, Guastalla JP, Rosso R, Marth C, Nooij M, Presti M, Scarabelli C, Splinter TAW, Ploch E, Beex LVA, ten Bokkel Huinink W, Forni M, Melpignano M, Blake P, Kerbrat P, Mendiola C, Cervantes A, Goupil A, Harper PG, Madronal C, Namer M, Scarfone G, Stoot JEGM, Teodorovic I, Coens C, Vergote I, Vermorken JB.
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group.
Ann Oncol 2003; 14: 441-448
We do not assume any responsibility for the contents of the web pages of other providers.